ISRCTN16139487
Completed
Not Applicable
Autologous bone marrow stem cell transplantation in patients with decompensated liver cirrhosis: results from first in man study
. Kipshidze Central University Hospital (Georgia)0 sites34 target enrollmentApril 15, 2015
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Decompensated liver cirrhosis
- Sponsor
- . Kipshidze Central University Hospital (Georgia)
- Enrollment
- 34
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Chronic hepatic failure
- •2\. Ultrasonographic evidences of cirrhosis and portal hypertension
- •3\. Child\-Pough class B and C score
- •4\. Patients must have the ability to sign the informed consent
Exclusion Criteria
- •1\. Patients aged less than 18 or more than 70
- •2\. Hepatopulmonary syndrome
- •3\. Documented hepatocellular carcinoma or history of other cancer
- •4\. Presence of hepatic, portal or splenic vein thrombosis on doppler ultrasonography
- •5\. History of autoimmune diseases
- •6\. Use of hepatotoxic drugs within the last 6 month before enrolment
- •7\. Decompensated heart failure
- •8\. Renal failure (creatinine \>2\.5 mg/dL)
- •9\. International normalized ratio (INR) \>2\.2
- •10\. Patients with acute infection
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Safety and Efficacy of Autologous bone marrow stem cells for treatment of Chronic Renal FailureCTRI/2010/091/001048International Stemcell Services Limited117, Venkateshwara Nagar, Jakkur, Bengaluru 5600645
Completed
Not Applicable
Autologous bone marrow cells in patients with critical limb ischemiaISRCTN16096154ational Institute of Heart and Vascular Diseases62
Active, not recruiting
Phase 1
Bone marrow stem cell transplantation after acute spinal cord injuryHealth Condition 1: null- Traumatic Acute Complete Spinal Cord Injury T1-T12 ( neurological level)CTRI/2014/01/004316Indian Council of Medical Research21
Completed
Not Applicable
Selected autologous bone marrow cell transplant following trans-mural myocardial infarction in patients undergoing coronary surgery: A prospective, double-blind, randomised controlled trialISRCTN65630838nited Bristol Healthcare NHS Trust (UK)60
Recruiting
Phase 1
Safety and efficacy of autologous stem cells derived from bone marrow in treating OsteoarthritisCTRI/2010/091/001044International Stemcell Services Limited117, Venkateshwara Nagar, Jakkur, Bengaluru 56006410